The company’s U.S.-listed shares fell over 13% in premarket trading and dragged down other stocks in the industry between 2% and 5%. Medical cannabis was the only bright spot, while Canopy’s revenue from recreational markets at home in Canada and internationally slumped in double-digit percentages. Ontario-based Canopy Growth’s net loss attributable to the company widened to C$1.30 billion ($946.21 million), or C$3.72 per share, in the quarter ended March 31, from C$379.5 million, or C$1.10 per share, a year ago.

from Yahoo Finance https://ift.tt/2Ak8KwU

Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Emily McCormick discuss the AT&T-Salesforce deal, and Salesforce’s latest earnings report.

from Yahoo Finance https://ift.tt/36LIhEG

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

from Yahoo Finance https://ift.tt/2XdFiBr